TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
SPRB

Spruce Biosciences, Inc.

Healthcare · Biotechnology

47.50$ -2.5% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Spruce Biosciences, Inc. (SPRB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 103 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SPRB
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
113 104 88 76 65 45 32 22 15 53 56 103
111 102 86 74 64 44 31 21 15 52 55 101
99 96 81 70 60 39 26 16 11 49 54 96
108 96 81 70 60 – 26 16 11 49 54 96
28 27 21 16 13 16 16 8.6 9.9 11 22 19
24 24 18 14 12 15 16 8.1 9.4 10 12 11
1.9 1.9 1.9 1.9 1.9 – 1.6 1.2 0.8 0.3 1.3 2.8
3.2 3.3 1.9 0.7 1.8 1.3 1.9 0.8 1.4 0.9 2.7 1.2
2.1 1.7 1.3 0.9 0.5 0.1 – – – – 5.5 4.6
85 77 67 59 52 29 15 13 5.4 43 35 84
-187 -197 -209 -218 -227 -250 -264 -266 -275 -289 -302 -318
0.5 0.5 0.5 0.5 0.5 0.6 0.6 0.6 0.6 0.8 1.4 2.4

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?